Existing allergy drug shows promise for people with tick-borne meat allergy

ALBANY — An existing allergy medication may offer new hope to people with alpha-gal syndrome, a tick-borne condition that can cause potentially life-threatening reactions to red meat and other mammalian products, according to new research.

The study, led by a North Carolina researcher and presented at the American College of Allergy, Asthma and Immunology’s annual meeting on Thursday, found that people with the condition experienced significant improvements in symptoms while taking omalizumab, a medication already used to treat asthma, hives and other allergic reactions.

Alpha-gal syndrome is associated with bites from the Lone Star tick, once found primarily in the South and mid-Atlantic states, but now spreading north. Scientists first confirmed the tick in New York in 1990. It is now common on Long Island and is established in 16 upstate counties, including Ulster, Sullivan and Albany…

Story continues

TRENDING NOW

LATEST LOCAL NEWS